FDA
-
-
-
-
-
-
-
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Raised to $53 at Barclays
-
-
-
-
-
-
-
Scholar Rock Highlights 2026 Strategic Priorities
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Lowered to $48 at Leerink Partners
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Lowered to $45 at BMO Capital
-
-
-
-
-
-
-
Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress
-
-
-
-
-
-
-
Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress
-
327,801 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

